keyword
https://read.qxmd.com/read/38525008/il-12-overexpressed-nanoparticles-suppress-the-proliferation-of-melanoma-through-inducing-icd-and-activating-dc-cd8-t-and-cd4-t-cells
#1
JOURNAL ARTICLE
Huan-Huan Shen, Jie-Fei Peng, Ran-Ran Wang, Ping-Yu Wang, Jia-Xiang Zhang, Hong-Fang Sun, Yan Liang, Yan-Mei Li, Jiang-Nan Xue, You-Jie Li, Guang-Bin Sun, Shu-Yang Xie
PURPOSE: The drug resistance and low response rates of immunotherapy limit its application. This study aimed to construct a new nanoparticle (CaCO3 -polydopamine-polyethylenimine, CPP) to effectively deliver interleukin-12 (IL-12) and suppress cancer progress through immunotherapy. METHODS: The size distribution of CPP and its zeta potential were measured using a Malvern Zetasizer Nano-ZS90. The morphology and electrophoresis tentative delay of CPP were analyzed using a JEM-1400 transmission electron microscope and an ultraviolet spectrophotometer, respectively...
2024: International Journal of Nanomedicine
https://read.qxmd.com/read/38493479/integration-of-%C3%AE-deficient-cars-into-the-cd3-zeta-gene-conveys-potent-cytotoxicity-in-t-and-nk-cells
#2
JOURNAL ARTICLE
Jonas Kath, Clemens Franke, Vanessa Drosdek, Weijie Du, Viktor Glaser, Carla Fuster-Garcia, Maik Stein, Tatiana Zittel, Sarah Schulenberg, Caroline E Porter, Lena Andersch, Annette Künkele, Joshua Alcaniz, Jens Hoffmann, Hinrich Abken, Mohamed Abou-El-Enein, Axel Pruß, Masataka Suzuki, Toni Cathomen, Renata Stripecke, Hans-Dieter Volk, Petra Reinke, Michael Schmueck-Henneresse, Dimitrios Laurin Wagner
Chimeric antigen receptor (CAR)-redirected immune cells hold significant therapeutic potential for oncology, autoimmune diseases, transplant medicine, and infections. All approved CAR-T therapies rely on personalized manufacturing using undirected viral gene transfer, which results in non-physiological regulation of CAR-signaling and limits their accessibility due to logistical challenges, high costs and biosafety requirements. Random gene transfer modalities pose a risk of malignant transformation by insertional mutagenesis...
March 17, 2024: Blood
https://read.qxmd.com/read/38262114/enhancing-humoral-and-mucosal-immune-response-of-ped-vaccine-candidate-by-fusing-s1-protein-to-nanoparticle-multimerization
#3
JOURNAL ARTICLE
Minghui Li, Xueke Sun, Yilan Chen, Siqiao Wang, Qin Li, Yanan Wang, Yue Wang, Ruiqi Li, Peiyang Ding, Gaiping Zhang
Porcine epidemic diarrhea virus (PEDV) is a highly infectious pathogen with a high mortality rate, which poses a serious threat to newborn piglets. A rapid, safe and effective vaccine is necessary for protecting pigs from PED infection. Nanoparticles have become molecular scaffolds for displaying soluble antigens due to their unique physical and chemical properties. Here, a vaccine candidate was based on the display of PEDV S1 protein on a mi3 nanoparticle platform using SpyTag/SpyCatcher technology. The size, zeta potential and microstructure of the S1-mi3 NPs were investigated, and their effects on the uptake of antigen-presenting cells (APCs) and maturation of dendritic cells (DCs) were analyzed...
January 19, 2024: Veterinary Microbiology
https://read.qxmd.com/read/38116030/integration-of-%C3%AE-deficient-cars-into-the-cd3-zeta-gene-conveys-potent-cytotoxicity-in-t-and-nk-cells
#4
Jonas Kath, Clemens Franke, Vanessa Drosdek, Weijie Du, Viktor Glaser, Carla Fuster-Garcia, Maik Stein, Tatiana Zittel, Sarah Schulenberg, Caroline E Porter, Lena Andersch, Annette Künkele, Joshua Alcaniz, Jens Hoffmann, Hinrich Abken, Mohamed Abou-El-Enein, Axel Pruß, Masataka Suzuki, Toni Cathomen, Renata Stripecke, Hans-Dieter Volk, Petra Reinke, Michael Schmueck-Henneresse, Dimitrios L Wagner
UNLABELLED: Chimeric antigen receptor (CAR)-reprogrammed immune cells hold significant therapeutic potential for oncology, autoimmune diseases, transplant medicine, and infections. All approved CAR-T therapies rely on personalized manufacturing using undirected viral gene transfer, which results in non-physiological regulation of CAR-signaling and limits their accessibility due to logistical challenges, high costs and biosafety requirements. Here, we propose a novel approach utilizing CRISPR-Cas gene editing to redirect T cells and natural killer (NK) cells with CARs...
November 14, 2023: bioRxiv
https://read.qxmd.com/read/38070794/preparation-characterization-and-immune-response-of-chitosan%C3%A2-gold-loaded-myricaria-germanica-polysaccharide
#5
JOURNAL ARTICLE
Yi Wang, Fuan Qiu, Qiang Zheng, Ancan Hong, Tao Wang, Junwen Zhang, Lifan Lin, Zhe Ren, Tao Qin
In this study, a novel nano-drug delivery system (CS-Au NPs) based on gold nanoparticles (Au NPs) and chitosan (CS) that modified Myricaria germanica polysaccharide (MGP) was developed to enhance immune responses. At a MGP to CS Au ratio of 5:1, CS-Au-MGP NPs had a loading capacity of 78.27 %. The structure of CS-Au-MGP NPs were characterized by Transmission electron microscope, TEM-energy dispersive spectroscopy mapping, Fourier transform infrared spectroscopy, X-ray photoelectron spectrometer, particle size and zeta-potential distribution analysis...
December 7, 2023: International Journal of Biological Macromolecules
https://read.qxmd.com/read/37868834/biomarkers-in-the-pathogenesis-diagnosis-and-treatment-of-systemic-sclerosis
#6
REVIEW
Maheswari Muruganandam, Angie Ariza-Hutchinson, Rosemina A Patel, Wilmer L Sibbitt
Systemic sclerosis (SSc) is a complex autoimmune disease characterized by vascular damage, vasoinstability, and decreased perfusion with ischemia, inflammation, and exuberant fibrosis of the skin and internal organs. Biomarkers are analytic indicators of the biological and disease processes within an individual that can be accurately and reproducibly measured. The field of biomarkers in SSc is complex as recent studies have implicated at least 240 pathways and dysregulated proteins in SSc pathogenesis. Anti-nuclear antibodies (ANA) are classical biomarkers with well-described clinical classifications and are present in more than 90% of SSc patients and include anti-centromere, anti-Th/To, anti-RNA polymerase III, and anti-topoisomerase I antibodies...
2023: Journal of Inflammation Research
https://read.qxmd.com/read/37833951/the-tyrosine-phosphatase-activity-of-ptpn22-is-involved-in-t-cell-development-via-the-regulation-of-tcr-expression
#7
JOURNAL ARTICLE
Bin Bai, Tong Li, Jiahui Zhao, Yanjiao Zhao, Xiaonan Zhang, Tao Wang, Na Zhang, Xipeng Wang, Xinlei Ba, Jialin Xu, Yang Yu, Bing Wang
The protein tyrosine phosphatase PTPN22 inhibits T cell activation by dephosphorylating some essential proteins in the T cell receptor (TCR)-mediated signaling pathway, such as the lymphocyte-specific protein tyrosine kinase (Lck), Src family tyrosine kinases Fyn, and the phosphorylation levels of Zeta-chain-associated protein kinase-70 (ZAP70). For the first time, we have successfully produced PTPN22 CS transgenic mice in which the tyrosine phosphatase activity of PTPN22 is suppressed. Notably, the number of thymocytes in the PTPN22 CS mice was significantly reduced, and the expression of cytokines in the spleen and lymph nodes was changed significantly...
September 25, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/36669607/lymphocyte-disturbance-and-functional-assessment-of-the-asp521asn-zap70-mutation
#8
JOURNAL ARTICLE
Yung-Feng Lin, Wen-I Lee, Ching-Huang Ho, Shih-Hsiang Chen, Mei-Hsin Hsu, Ren-Chin Wu, Wan-Fang Lee, Tang-Her Jaing, Jing-Long Huang, Shih-Feng Tsai
Activated zeta-chain-associated protein kinase 70 (ZAP70) phosphorylates the TCRαβ:CD3:zeta complex to diversify and amplify TCR signaling. Patients with ZAP70 mutations can present with phenotypes of immune dysregulation as well as infection. We identified the first Taiwanese boy with the [Asp521Asn] ZAP70 mutation who presented with recurrent pneumonia, inflammatory bowel disease-like diarrhea, transient hematuria and autoimmune hepatitis. He had isolated CD8 lymphopenia, eosinophilia, hypogammaglobulinemia, and impaired lymphocyte proliferation...
January 17, 2023: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/36590097/an-opinion-on-the-debatable-function-of-brain-resident-immune-protein-t-cell-receptor-beta-subunit-in-the-central-nervous-system
#9
JOURNAL ARTICLE
Pragya Komal, S K V Manjari, Raad Nashmi
In recent years scientific research has established that the nervous and immune systems have shared molecular signaling components. Proteins native to immune cells, which are also found in the brain, have neuronal functions in the nervous system where they affect synaptic plasticity, axonal regeneration, neurogenesis, and neurotransmission. Certain native immune molecules like major histocompatibility complex I (MHC-I), paired immunoglobulin receptor B (PirB), toll-like receptor (TLR), cluster of differentiation-3 zeta (CD3ζ), CD4 co-receptor, and T-cell receptor beta (TCR-β) expression in neurons have been extensively documented...
December 2022: IBRO neuroscience reports
https://read.qxmd.com/read/36530917/exploring-modulations-in-t-cell-receptor-mediated-t-cell-signaling-events-in-systemic-circulation-and-at-local-disease-site-of-patients-with-tubercular-pleural-effusion-an-attempt-to-understand-tuberculosis-pathogenesis-at-the-local-disease-site
#10
JOURNAL ARTICLE
Bhawna Sharma, Diwakar Rathour, Sumbul Uddin, Beenu Joshi, Devendra Singh Chauhan, Santosh Kumar
INTRODUCTION: T cells are crucial for pathogenesis as well as control for tuberculosis (TB). Although much is known about the signaling pathways which are required for the activation of T cells during acute infection but the way these cells respond during persistent of infection still remained elusive. Therefore, it is rationale to understand T cell activation during tuberculous pleural effusion (TPE), which is similar to bacterial persistency system. METHODS: Herein, we will employ T cell receptor (TCR) based approaches for studying events of T cell activation pathways in cells of blood and pleural fluid among patients with TPE...
2022: Frontiers in Medicine
https://read.qxmd.com/read/36164204/ct-167-using-the-sodium-iodide-symporter-to-visualize-car-t-cell-trafficking
#11
JOURNAL ARTICLE
Brynn B Duncan, Justin Mirazee, Christopher Chien, Stefan Cordes, Sogun Hong, Noriko Sato, David Young, Cynthia E Dunbar
BACKGROUND: Chimeric antigen receptor T (CAR-T) cell therapy revolutionized the treatment of refractory B cell malignancies, but relapses occur through a variety of incompletely understood mechanisms. Currently, tracking CAR-T expansion and persistence in patients is limited to peripheral blood sampling, but this approach provides no insights into how and where CAR-T cells traffic beyond the peripheral blood or how cellular localization may impact persistence and efficacy. Furthermore, costimulatory endodomains that are known to influence CAR-T cell phenotype have unclear downstream effects on how CAR-T cells traffic...
October 2022: Clinical Lymphoma, Myeloma & Leukemia
https://read.qxmd.com/read/35737298/preclinical-efficacy-of-bcma-directed-car-t-cells-incorporating-a-novel-d-domain-antigen-recognition-domain
#12
JOURNAL ARTICLE
Janine M Buonato, Justin P Edwards, Liubov Zaritskaya, Alexandra R Witter, Ankit Gupta, David W LaFleur, David A Tice, Laura K Richman, David M Hilbert
Chimeric antigen receptor (CAR) T-cell therapies directed against B-cell maturation antigen (BCMA) have shown compelling clinical activity and manageable safety in subjects with relapsed and refractory multiple myeloma (RRMM). Prior reported CAR T cells have mostly used antibody fragments such as humanized or murine single-chain variable fragments or camelid heavy-chain antibody fragments as the antigen recognition motif. Herein, we describe the generation and preclinical evaluation of ddBCMA CAR, which uses a novel BCMA binding domain discovered from our D domain phage display libraries and incorporates a 4-1BB costimulatory motif and CD3-zeta T-cell activation domain...
July 5, 2022: Molecular Cancer Therapeutics
https://read.qxmd.com/read/34991927/effective-improvements-to-the-live-attenuated-newcastle-disease-virus-vaccine-by-polyethylenimine-based-biomimetic-silicification
#13
JOURNAL ARTICLE
Jinjin Zhang, Yanhong Ji, Zhengxiang Wang, Yane Jia, Qiyun Zhu
Live and killed vaccines impart a significant role in preventing of Newcastle disease (ND) in China. Vaccine efficacy could be ameliorated by improving vaccine-induced cellular immunity and antibody persistency. Previous studies substantiated the potency of silicon dioxide (SiO2 ) in the control-release of drugs and as a vaccine adjuvant, and polyethylenimine (PEI) merits as a mucosal adjuvanticity with electro-positivity. The present study employed SiO2 and PEI to prepare biomimetic silicon mineralized nanoparticle G7M@SiO2 -PEI and microparticle (SiO2  + PEI)@G7M vaccines of G7M, a candidate for live attenuated vaccine of genotype VII Newcastle disease virus (NDV)...
January 3, 2022: Vaccine
https://read.qxmd.com/read/34880861/cd247-a-potential-t-cell-derived-disease-severity-and-prognostic-biomarker-in-patients-with-idiopathic-pulmonary-fibrosis
#14
JOURNAL ARTICLE
Yupeng Li, Shibin Chen, Xincheng Li, Xue Wang, Huiwen Li, Shangwei Ning, Hong Chen
Background: Idiopathic pulmonary fibrosis (IPF) has high mortality worldwide. The CD247 molecule (CD247, as known as T-cell surface glycoprotein CD3 zeta chain) has been reported as a susceptibility locus in systemic sclerosis, but its correlation with IPF remains unclear. Methods: Datasets were acquired by researching the Gene Expression Omnibus (GEO). CD247 was identified as the hub gene associated with percent predicted diffusion capacity of the lung for carbon monoxide (Dlco% predicted) and prognosis according to Pearson correlation, logistic regression, and survival analysis...
2021: Frontiers in Immunology
https://read.qxmd.com/read/34729377/novel-tcr-like-car-t-cells-targeting-an-hla%C3%A2-0201-restricted-ssx2-epitope-display-strong-activity-against-acute-myeloid-leukemia
#15
JOURNAL ARTICLE
Scott Raskin, Stacey Van Pelt, Keri Toner, Preethi Bala Balakrishnan, Hema Dave, Catherine M Bollard, Eric Yvon
The synovial sarcoma X breakpoint 2 (SSX2) belongs to a multigene family of cancer-testis antigens and can be found overexpressed in multiple malignancies. Its restricted expression in immune-privileged normal tissues suggest that SSX2 may be a relevant target antigen for chimeric antigen receptor (CAR) therapy. We have developed a T cell receptor (TCR)-like antibody (Fab/3) that binds SSX2 peptide 41-49 (KASEKIFYV) in the context of HLA-A∗-0201. The sequence of Fab/3 was utilized to engineer a CAR with the CD3 zeta intra-cellular domain along with either a CD28 or 4-1BB costimulatory endodomain...
December 10, 2021: Molecular Therapy. Methods & Clinical Development
https://read.qxmd.com/read/34533125/-establishment-of-chimeric-antigen-receptor-nk92mi-cells-recognizing-hbsag
#16
JOURNAL ARTICLE
Shasha Dong, Min Huang, Dongdong Li, Yu Gao, Zhenghong Li, Chuanmiao Liu
Objective To construct a lentiviral expression vector of chimeric antigen receptor (CAR) recognizing hepatitis B surface antigen (HBsAg) and make it expressed in NK92MI cells. Methods The CAR was designed and synthesized with the sequence of single chain variable fragment (scFv). Next it was cloned into a lentivirus expression vector, followed by packaging, concentration and titer determination. Then HEK293T cells were transduced with the concentrated lentivirus. The expression of CD3 zeta chain and the infection efficiency in the NK92MI cells were detected by Western blotting...
September 2021: Xi Bao Yu Fen Zi Mian Yi Xue za Zhi, Chinese Journal of Cellular and Molecular Immunology
https://read.qxmd.com/read/34279263/amorphous-crystalline-calcium-phosphate-coating-promotes-in-vitro-growth-of-tumor-derived-jurkat-t-cells-activated-by-anti-cd2-cd3-cd28-antibodies
#17
JOURNAL ARTICLE
Yurii P Sharkeev, Ekaterina G Komarova, Valentina V Chebodaeva, Mariya B Sedelnikova, Aleksandr M Zakharenko, Kirill S Golokhvast, Larisa S Litvinova, Olga G Khaziakhmatova, Vladimir V Malashchenko, Kristina A Yurova, Natalia D Gazatova, Ivan G Kozlov, Marina Y Khlusova, Konstantin V Zaitsev, Igor A Khlusov
A modern trend in traumatology, orthopedics, and implantology is the development of materials and coatings with an amorphous-crystalline structure that exhibits excellent biocopatibility. The structure and physico-chemical and biological properties of calcium phosphate (CaP) coatings deposited on Ti plates using the micro-arc oxidation (MAO) method under different voltages (200, 250, and 300 V) were studied. Amorphous, nanocrystalline, and microcrystalline statesof CaHPO4 and β-Ca2 P2 O7 were observed in the coatings using TEM and XRD...
July 1, 2021: Materials
https://read.qxmd.com/read/34063174/cord-blood-t-cells-expressing-high-and-low-pkc%C3%AE-levels-develop-into-cells-with-a-propensity-to-display-th1-and-th9-cytokine-profiles-respectively
#18
JOURNAL ARTICLE
Khalida Perveen, Alex Quach, Andrew McPhee, Susan L Prescott, Simon C Barry, Charles S Hii, Antonio Ferrante
Low Protein Kinase C zeta (PKCζ) levels in cord blood T cells (CBTC) have been shown to correlate with the development of allergic sensitization in childhood. However, little is known about the mechanisms responsible. We have examined the relationship between the expression of different levels of PKCζ in CBTC and their development into mature T cell cytokine producers that relate to allergy or anti-allergy promoting cells. Maturation of naïve CBTC was initiated with anti-CD3/-CD28 antibodies and recombinant human interleukin-2 (rhIL-2)...
May 5, 2021: International Journal of Molecular Sciences
https://read.qxmd.com/read/33676898/packed-red-blood-cells-inhibit-t-cell-activation-via-ros-dependent-signaling-pathways
#19
JOURNAL ARTICLE
Marlene C Gerner, Andrea Bileck, Lukas Janker, Liesa S Ziegler, Thomas Öhlinger, Pierre Raeven, Ernst W Müllner, Ulrich Salzer, Christopher Gerner, Klaus G Schmetterer, David M Baron
Numerous observations indicate that red blood cells (RBCs) affect T-cell activation and proliferation. We have studied effects of packed RBCs (PRBCs) on T-cell receptor (TCR) signaling and the molecular mechanisms whereby (P)RBCs modulate T-cell activation. In line with previous reports, PRBCs attenuated the expression of T-cell activation markers CD25 and CD69 upon costimulation via CD3/CD28. In addition, T-cell proliferation and cytokine expression were markedly reduced when T-cells were stimulated in the presence of PRBCs...
January 2021: Journal of Biological Chemistry
https://read.qxmd.com/read/33287637/design-and-assessment-of-novel-anti-cd30-cars-with-human-antigen-recognition-domains
#20
JOURNAL ARTICLE
Stephanie Choi, Melissa A Pegues, Norris Lam, Claudia Geldres, Danielle Vanasse, James N Kochenderfer
Chimeric antigen receptors are artificial fusion proteins that incorporate antigen-recognition domains and T-cell signaling domains. CD30 is a cell-surface protein expressed on Hodgkin lymphoma (HL), some T-cell lymphomas, and some B-cell lymphomas. CD30 has a restricted expression pattern in normal cells, so CD30 has good potential as a clinical target for CAR T cells. We compared 3 different anti-CD30 CAR designs incorporating a single-chain variable fragment derived from the 5F11 fully-human monoclonal antibody...
December 7, 2020: Human Gene Therapy
keyword
keyword
56874
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.